COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

CUREDRPLA INC

BROOKLYN, NY · EIN 843925441 · Form 990PF · FY2025 · NTEE E19 · Health Care · Small ($100K-$1M)
revenue
$828K
expenses
$66K
net assets
$139K
employees
profile · synthesized from sources

CUREDRPLA INC is a nonprofit organization based in New York dedicated to advancing research for Dentatorubral-Pallidoluysian Atrophy (DRPLA), a rare genetic neurodegenerative disorder. The organization supports scientific investigation and treatment development by funding research institutions and international partners. Its primary activity is granting funds to universities and health research entities working on DRPLA.

named programs · 1 · from sources

What they call their work

DRPLA Research Funding Program
Provides grants to academic and medical research institutions to advance understanding and treatment of DRPLA
activities · 1 group

What they do

  • Genetic and Neurological Disease Research Funding 2 activities
    • Funding DRPLA research through grants to academic and medical institutions
      Provides financial support to universities and medical centers, including Boston Children's Hospital, Columbia University, Mass General, and the University of Washington, to advance research toward treatments for DRPLA.
    • Funding DRPLA research through grants to nonprofit organizations
      Provides grants to nonprofit organizations such as Ataxia UK and the N Lorem Foundation to support research and initiatives aimed at advancing treatment for DRPLA.
financials · form 990PF · fy2025
revenue
Total revenue$828K
Contributions & grants$828K100%
Program service revenue
Investment income$320%
Other revenue
expenses
Total expenses$66K
Program expenses
Admin / overhead
Fundraising
Salaries & benefits$0
Grants paid out$619K
balance sheet
Total assets$139K
Cash
Investments
Liabilities
Net assets$139K
5 years on record · 2020–2025 · YoY revenue -13.9%
relationships · 6

Who they work with

  • Ataxia UK (Care of Charities Aid Foundation) Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
  • Boston Children's Hospital Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
  • Columbia University Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
  • Mass General Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
  • N Lorem Foundation Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
  • University of Washington Partner — Recipient of grants from CUREDRPLA INC to support DRPLA research and treatment development.
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Research Grantmaking for DRPLA Treatment Advancement
    methodology: research_grantmaking
    By funding external research institutions to conduct scientific studies, we advance the development of treatments for DRPLA, because targeted financial support accelerates biomedical innovation and clinical discovery.